Your browser doesn't support javascript.
loading
Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations.
Goldman, Jennifer L; Kalu, Ibukunoluwa C; Schuster, Jennifer E; Erickson, Tyler; Mast, Dana Keener; Zimmerman, Kanecia; Benjamin, Daniel K; Kalb, Luther G; Gurnett, Christina; Newland, Jason G; Sherby, Michael; Godambe, Maya; Shinde, Nidhi; Watterson, Treymayne; Walsh, Tyler; Foxe, John; Zand, Martin; Dewhurst, Stephen; Coller, Ryan; DeMuri, Gregory P; Archuleta, Shannon; Ko, Linda K; Inkelas, Moira; Manuel, Vladimir; Lee, Rebecca; Oh, Hyunsung; Murugan, Vel; Kramer, Joanna; Okihiro, May; Gwynn, Lisa; Pulgaron, Elizabeth; McCulloh, Russell; Broadhurst, Jana; McDaniels-Davidson, Corinne; Kiene, Susan; Oren, Eyal; Wu, Yelena; Wetter, David W; Stump, Tammy; Brookhart, M Alan; Fist, Alex; Haroz, Emily.
Afiliación
  • Goldman JL; Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
  • Kalu IC; Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri.
  • Schuster JE; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Erickson T; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
  • Mast DK; Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
  • Zimmerman K; Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri.
  • Benjamin DK; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Kalb LG; Kennedy Krieger Institute, Baltimore, Maryland.
  • Gurnett C; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Newland JG; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
  • Sherby M; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Godambe M; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
  • Shinde N; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Watterson T; Department of Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Walsh T; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Foxe J; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Zand M; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Dewhurst S; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Coller R; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • DeMuri GP; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Archuleta S; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
  • Ko LK; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
  • Inkelas M; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
  • Manuel V; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
  • Lee R; Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, Washington.
  • Oh H; Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, Washington.
  • Murugan V; Department of Pediatrics, Washington University in St Louis, St Louis, Missouri.
  • Kramer J; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Okihiro M; UCLA Clinical and Translational Science Institute, Los Angeles, California.
  • Gwynn L; Center for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona.
  • Pulgaron E; Center for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona.
  • Broadhurst J; Center for Personalized Diagnostics, ASU Biodesign Clinical Testing Laboratory, Biodesign Institute, Arizona State University, Tempe, Arizona.
  • McDaniels-Davidson C; Division of Primary, Complex, and Adolescent Medicine, Phoenix Children's Hospital, Phoenix, Arizona.
  • Kiene S; University of Hawaii, Honolulu, Hawaii.
  • Oren E; Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.
  • Wu Y; University of Nebraska Medical Center, Omaha, Nebraska.
  • Wetter DW; University of Nebraska Medical Center, Omaha, Nebraska.
  • Stump T; Division of Epidemiology and Biostatistics, San Diego State University School of Public Health, San Diego, California.
  • Brookhart MA; Division of Epidemiology and Biostatistics, San Diego State University School of Public Health, San Diego, California.
  • Fist A; Department of Dermatology, University of Utah, Salt Lake City, Utah.
  • Haroz E; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Pediatrics ; 152(Suppl 1)2023 07 01.
Article en En | MEDLINE | ID: mdl-37394512
ABSTRACT

OBJECTIVE:

In April 2021, the US government made substantial investments in students' safe return to school by providing resources for school-based coronavirus disease 2019 (COVID-19) mitigation strategies, including COVID-19 diagnostic testing. However, testing uptake and access among vulnerable children and children with medical complexities remained unclear.

METHODS:

The Rapid Acceleration of Diagnostics Underserved Populations program was established by the National Institutes of Health to implement and evaluate COVID-19 testing programs in underserved populations. Researchers partnered with schools to implement COVID-19 testing programs. The authors of this study evaluated COVID-19 testing program implementation and enrollment and sought to determine key implementation strategies. A modified Nominal Group Technique was used to survey program leads to identify and rank testing strategies to provide a consensus of high-priority strategies for infectious disease testing in schools for vulnerable children and children with medical complexities.

RESULTS:

Among the 11 programs responding to the survey, 4 (36%) included prekindergarten and early care education, 8 (73%) worked with socioeconomically disadvantaged populations, and 4 focused on children with developmental disabilities. A total of 81 916 COVID-19 tests were performed. "Adapting testing strategies to meet the needs, preferences, and changing guidelines," "holding regular meetings with school leadership and staff," and "assessing and responding to community needs" were identified as key implementation strategies by program leads.

CONCLUSIONS:

School-academic partnerships helped provide COVID-19 testing in vulnerable children and children with medical complexities using approaches that met the needs of these populations. Additional work is needed to develop best practices for in-school infectious disease testing in all children.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Poblaciones Vulnerables / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Child / Humans Idioma: En Revista: Pediatrics Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Poblaciones Vulnerables / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Child / Humans Idioma: En Revista: Pediatrics Año: 2023 Tipo del documento: Article